Gluetacs Therapeutics

Company Deals Drug

Gluetacs Therapeutics Files IND for Molecular Glue Degrading Agent in China

Fineline Cube Sep 27, 2022

Gluetacs Therapeutics has reported filing an Investigational New Drug (IND) application for its first molecular...

Company Drug

Novo Nordisk semaglutide Alzheimer’s biomarkers fail primary endpoint

Company Medical Device

Acotec V-otter Microcatheter Secures NMPA Approval for TACE Procedures

Company Deals

Youjia-Bio Tongee-Medical Nucleic-Acid-Drug Partnership Targets Diabetes

Company Drug

Fosun-Pharma FXS0887 ATR-Inhibitor Gets NMPA Phase 1 Nod